N-Acetylcysteine Linked to Multiple Sclerosis Brain Gains
A small clinical study found that adults with multiple sclerosis reported reduced fatigue and pain while taking this supplement.
Updated on Oct. 13, 2026 in Stroke
Live Poll
Would you trust a non-prescription antioxidant supplement as a complement to your medical treatment plan?
In 2026, researchers reported that patients with multiple sclerosis who received N-acetylcysteine saw improvements in cognitive function, attention, fatigue, and pain levels. The study utilized an integrated PET-MRI platform to document these changes in brain activity.
Why it matters
Multiple sclerosis affects 2.8 million people, with 40 to 70% experiencing cognitive impairment. Researchers studied N-acetylcysteine because it is believed to help address oxidative stress, a known driver of neurodegeneration in the condition.
This randomized trial of 36 patients evaluated the impact of N-acetylcysteine over four months. Researchers observed significant improvements in patient-reported fatigue, pain, cognition, and attention alongside increased glucose metabolism in the frontal and temporal gyri.
The players
Thomas Jefferson University
An academic medical institution in Philadelphia where researchers studied the effects of N-acetylcysteine on multiple sclerosis.
The details
Participants in the treatment group received a combination of 50 mg/kg of intravenous N-acetylcysteine weekly and 500 mg of oral N-acetylcysteine twice daily. Imaging revealed connectivity alterations in the inferior frontal region, cerebellum, and parts of the temporal and parietal lobes. These findings suggest the intervention may modulate metabolic and structural pathways in the brain to potentially mitigate neurodegenerative processes.
Timeline
* Clinical study findings were published in 2026.
* Patients were treated and monitored over a period of 4 months.
Health Landscape
This study is part of an ongoing effort at Thomas Jefferson University to address the neurodegenerative mechanisms underlying multiple sclerosis. It adds to the medical science community's exploration of antioxidant therapies as potential complementary approaches to standard neuro-immunology care.
Because these findings are preliminary and based on a small sample, they do not establish a standard of care for treating multiple sclerosis. It is essential to have a conversation with your neurologist before starting any new supplement or altering your current treatment regimen.
The takeaway
N-acetylcysteine is being investigated for its potential to help manage cognitive and physical symptoms in multiple sclerosis patients by reducing oxidative stress. Keep track of your fatigue and cognitive changes, and discuss these metrics with your healthcare team at your next appointment.
What happens next
Future clinical research is planned to establish safe and effective long-term dosing regimens, optimal duration of use, and the timing of N-acetylcysteine therapy.
Further reading
Learn more about the latest research and support resources in our Stroke section.
Source note: This article includes information reported by MedPage Today.
Live Poll
Would you trust a non-prescription antioxidant supplement as a complement to your medical treatment plan?
